Bibliographic Details
| Title: |
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer. |
| Authors: |
Carneiro BA; University of Pittsburgh Cancer Institute, PA 15232, USA., Ramanathan RK, Fakih MG, Krishnamurthi SS, Lembersky BC, Stoller RG, Lancaster SL, Pinkerton RA, Crandall TL, Schmotzer AR, Potter DM, Bahary N |
| Source: |
Clinical colorectal cancer [Clin Colorectal Cancer] 2012 Mar; Vol. 11 (1), pp. 53-9. Date of Electronic Publication: 2011 Aug 02. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: |
Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
